Navigation Links
Conatus Pharmaceuticals Reports Positive Results of CTS-1027 in Multiple Preclinical Studies of Liver Disease
Date:11/5/2007

the integrity of the extracellular matrix. Excessive MMP activity has been demonstrated to occur in the liver in response to a variety of acute and chronic insults. This results in the loss of scaffolding that maintains the normal architecture of the liver and the recruitment and activation of inflammatory cells that perpetuate liver damage. In addition, important cytokines in the progression of liver damage, such as TGF-beta, stimulate the expression of MMPs from hepatic stellate cells, the main cell type involved in the pathology of fibrosis. MMPs are also well recognized to play an important and direct role in regulating inflammation. These dual activities of tissue remodeling and modulating inflammatory networks make MMPs an attractive target in the setting of acute and chronic liver disease.

Conatus Pharmaceuticals Inc. is a privately-held specialty pharmaceutical company engaged in the development of innovative human therapeutics to treat liver disease. Chronic liver disease affects millions of people worldwide and can be caused by many different conditions or "insults" to the liver including Hepatitis C and other viral infections, obesity, chronic alcohol abuse or autoimmune diseases. Conatus was founded by the executive management team of Idun Pharmaceuticals in July 2005 following the successful sale of Idun to Pfizer.

http://www.conatuspharma.com


'/>"/>
SOURCE Conatus Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014  Remedy Informatics, the ... healthcare delivery and life sciences research, announced that ... Foundation (NPF) to build the first-ever national patient ... cancer and pancreatitis. "The National Pancreas ... change that thoughtful and committed organizations can effect ...
(Date:7/14/2014)... , July 14, 2014 Valeant ... and TSX: VRX) today announced it has filed ... Act of 1976 (HSR) with the U.S. Federal ... of Allergan, Inc. (NYSE: AGN). ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a ...
(Date:7/14/2014)...  Diomics, Inc., provider of X-Swab™, a novel ... States Patent and Trademark Office has issued two ... sample collection materials, devices made from them, and ... The primary method of collecting ... DNA from a number of commercially-available swabs is ...
Breaking Medicine Technology:Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2
(Date:7/14/2014)... 14, 2014 The report “Intelligent ... [Physical Security, Life Safety, Facility Management], IT Technologies ... & Analysis (2014 - 2019)” defines and segments ... in-depth analysis and forecasting of revenues. The report ... restraints and opportunities impacting it, along with the ...
(Date:7/14/2014)... July 14, 2014 This report ... market in Americas. The analysis includes market size ... period and key company share data by revenue ... Brazil and Mexico. It uses data and information ... and in-house analysis. , Scope, ...
(Date:7/14/2014)... The Encino cosmetic dentist at Encino ... and porcelain veneers. These restorations are an excellent alternative ... greater loss of healthy tooth tissue. They work similarly ... on the tooth. Encino dentist Dr. Mastour and his ... they offer the most appropriate treatment recommendations for each ...
(Date:7/14/2014)... -- Being physically active in middle age appears to ... types of dementia, suggest the findings from two new ... exercise at various levels, especially in midlife, is beneficial ... Clinic, said in an Alzheimer,s Association news release. ... conclusive. More research is needed to determine the extent ...
(Date:7/14/2014)... 2014 Follow us ... chromatography or UPLC is a new and ... that involves the use of extremely small-sized ... chromatographic compounds. This highly sensitive qualitative and ... analysis of chromatography samples. UPLC functions on ...
Breaking Medicine News(10 mins):Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Encino Esthetic Dental Group is Now Offering Lumineers and Porcelain Veneers 2Health News:Staying Active May Help Prevent Dementia 2Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2
... , , WASHINGTON , Feb. 8 ... showed he has what it takes to win big. Not only does ... own Milk Mustache. The 13th annual winning football Milk Mustache ad runs ...   http://www.newscom.com/cgi-bin/prnh/20100208/AQ51302 ) , The famed running back is the latest superstar ...
... Nev. , Feb. 8 The Whittemore Peterson ... Donnica Moore , a distinguished women,s health expert, as its ... in its efforts to help raise awareness and funding for ... Fatigue Syndrome.   , "We are pleased to have a ...
... ... Health, a joint venture between Humility of Mary Health Partners (HMHP) , NEO ... Ohio,s first and only radiation oncology center with Elekta Volumetric Modulated Arc Therapy (VMAT), ... ...
... , , NORTHBROOK, Ill. , ... a global leader in environmental evaluation and certification, announces ... materials used in consumer and manufactured goods.  These standards ... scientific assessment and broad stakeholder collaboration.   , This ...
... the use of computed tomography (CT scans) in children ... of scans, according to a new study in ... link only) http://www.cmaj.ca/embargo/cmaj091421.pdf . More than 650,000 ... consciousness, amnesia, disorientation and/or vomiting are seen each year ...
... JRS Medical ... that the Company is donating a percentage of all of their January & February 2010 ... employees also are raising funds locally for victims of the tragic earthquake. , ... (PRWEB) February 8, 2010 -- JRS Medical ...
Cached Medicine News:Health News:Reggie Bush Takes Down Reggie Wayne in Battle for the Milk Mustache! 2Health News:Whittemore Peterson Institute Announces Renowned Health Expert as New Spokesperson 2Health News:Partners for Urology Health First in Ohio with New Radiation Therapy Technology 2Health News:Partners for Urology Health First in Ohio with New Radiation Therapy Technology 3Health News:UL Environment to Develop Sustainability Standards For Plastic 2Health News:New CATCH rule to determine need for CT scans in children with minor head injury 2Health News:JRS Medical Raises Funds for Devastated Victims in Haiti 2Health News:JRS Medical Raises Funds for Devastated Victims in Haiti 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: